Rapidly Scalable COVID-19 Surveillance Program
PRIMARY OBJECTIVE(s)
Track the spread of the COVID-19 epidemic by syndromic surveillance and longitudinal serosurveillance in parts of the state covered by participating health care systems. Utilize Electronic Health Record data to further characterize the epidemic and to regularly monitor for sequelae of infection.
David Herrington and John Sanders
1) Clinical and laboratory monitoring through EMR. 2) Serosurveillance utilizing at home testing or collection. 3) Viral testing utilizing at home collection.
1) Scanwell Health application using lateral flow assay (Syntron or Innovita). 2) Neoteryx mitra collection device at home process through LabCorp for EIA testing. 3) Viral testing utilizing Curative method (George Washington) or Yale method (Quest).
1) Scanwell Health application using lateral flow assay (Syntron or Innovita). 2) Neoteryx mitra collection device at home process through LabCorp for EIA testing;
